II. Symptoms
- See Pain Scale
- See Pain Assessment in Advanced Dementia Scale
- Assess patient's pain with a self rating Pain Scale
- Scale
- No pain: 0
- Mild pain: 1-4
- Moderate pain: 5-6
- Severe pain: 7-10
III. Management: WHO Analgesic Ladder
- Step 1: Mild Pain (pain score of 1 to 4)
- Adequate analgesia for 20-25% of cancer patients
- Acetaminophen
- Aspirin
- NSAIDs or COX2 Inhibitors
- Step 2: Moderate Pain (pain score of 5 to 6)
- Acetaminophen with Codeine (Tylenol #3)
- Acetaminophen with Hydrocodone (Vicodin, Lorcet)
- Tramadol (Ultram)
- Step 3: Severe Pain (pain score of 7 to 10)
- Morphine Sulfate
- Hydromorphone (Dilaudid)
- Transdermal Fentanyl
- Levorphanol
- Methadone
- Cheap and effective (esp. neuropathic pain)
- Half-Life varies considerably (from 7 to 72 hours)
- Prescriptions typically limited to Palliative Care and pain management specialists
- Avoid Meperidine (Demerol)
- Too short acting, lower efficacy
- Intractable Pain (Emergency Department)
- Opioids as above (e.g. Morphine, Hydromorphone)
- Lidocaine (8 mg/ml)
- Bolus: 1.5 mg/kg IV (up to 100 mg) delivered over 20-30 minutes
- Infusion: 0.5 to 2 mg/kg/hour (up to 100 mg/hour)
- Ketamine (Analgesic, low dose)
- Dose: 0.1 to 0.2 mg/kg IV
- Effective in refractory non-Cancer Pain
- However, evidence for benefit in cancer-related pain is lacking
- Cannabinoids
- Limited evidence to date of benefit in Cancer Pain
- Epidural or intrathecal medications
- Opioids (Morphine, Hydromorphone)
- Ziconotide (Calcium Channel Blocker)
- Baclofen
- Bupivicaine
- Clonidine
- Other neuropathic pain agents
- Refractory Pain at the End of Life
- Severe, refractory cancer Pain at the End of Life may require very high doses of Opioid Analgesics
- These very high doses may result in apnea, and could shorten a patient's life
- When the goals of care are pain relief (not euthanasia), high doses are ethically supported
- Palliative Sedation
- Consider in severe patient suffering despite maximal medical therapy
- Palliative Sedation (StatPearls)
- Severe, refractory cancer Pain at the End of Life may require very high doses of Opioid Analgesics
IV. Dosing: Routes of Administration
- Oral Route (90% of cancer cases, preferred route)
- Peak effect in 1 hour after dosing
- Sublingual Route
- Subcutaneous (5% of cancer cases)
- Programmed Subcutaneous pump is first choice option
- Peak effect 20-30 minutes after dosing
- Intravenous
- Not typically used for Cancer Pain Management outside of hospital care
- Peak effect 10 minutes after dose
- Transdermal
- Rectal (5% of cancer cases)
- Many oral preparations may be given rectally (e.g. MS Contin tablets)
- Avoid regular Intramuscular dosing (no indication)
V. Management: Somatic pain including bone metastases
- Pain Characteristics
- Medications: General
- See Cancer Pain Narcotics
- COX2 Inhibitors (e.g. Vioxx or Celebrex)
- Nonsteroidal Antiinflammatory drugs (NSAIDs)
- Radioactive Strontium
- Medications: Bone Metastases
- Bisphosphonates
- Pamidronate (Aredia) 90 mg IV over 2-4 hours qMonth
- Calcitonin
- Corticosteroids
- Prednisone 30 to 60 mg/day PO
- Dexamethasone 16 mg/day PO
- Methylprednisolone 120 mg/day PO
- Bisphosphonates
VI. Management: Neuropathic pain
- Type I: Chronic Lancinating Pain (Paroxysmal pain)
- Characteristics
- Sudden sharp, stabbing or "Zinger" pain
- Sudden knifelike pain
- Medications
- Gabapentin (Neurontin) 100 mg PO tid
- Pregabalin (Lyrica)
- Carbamazepine (Tegretol) 200 mg PO bid
- Valproic Acid (Depakote) 10 mg/kg/day PO
- Clonazepam (Klonopin) 0.5 mg PO tid
- Lamotrigine (Lamictal) 50 mg PO qd
- Baclofen (Lioresal) 5 mg PO tid
- Characteristics
- Type II: Continuous Dysesthesias
- Characteristics
- Continuous burning
- Continuous electrical Sensations
- Medications
- Tricyclic Antidepressants
- Amitriptyline (Elavil) 30 to 100 mg PO qhs
- Doxepin (Sinequan) 50 to 75 mg PO qhs
- Imipramine (Tofranil) 50 to 75 mg PO qhs
- Systemic Anesthetics
- Mexiletine (Mexitil) 200 mg PO q8 hours
- Tocainide (Tonocard) 400 mg PO q8 hours
- Other medications for refractory pain
- Tricyclic Antidepressants
- Characteristics
- Localized pain
VII. Management: Visceral Pain
- Characteristics
- Squeezing
- Cramping
- Pressure-like pain
- Causes
- Hepatic metastases
- Biliary obstruction
- Bowel Obstruction
- Pancreatitis
- Medications
- General analgesia
- Capsule swelling (e.g. hepatic)
- Bowel Obstruction
- Biliary Colic
VIII. References
- Glauser and Money (2019) Crit Dec Emerg Med 23(8): 3-10
- Abrahm (1999) Ann Intern Med 131:37-46 [PubMed]
- Cherny (2000) CA Cancer J Clin 50(2):70-116 [PubMed]
- Groninger (2014) Am Fam Physician 90(1): 26-32 [PubMed]
- Levy (1996) N Engl J Med 335:1124-32 [PubMed]
- Miller (2001) Am Fam Physician 64(7):1227-34 [PubMed]